16 | Monoclonal AntibodiesIBA
01/2021
-
01/2012 |
11 | carotuximabIBA
09/2018
-
03/2012 |
10 | Pharmaceutical PreparationsIBA
09/2018
-
03/2012 |
9 | Amyloid (Amyloid Fibrils)IBA
01/2020
-
01/2014 |
9 | Silicon Dioxide (Silica)FDA LinkGeneric
11/2019
-
10/2013 |
7 | EndoglinIBA
09/2018
-
07/2011 |
6 | Radioisotopes (Radionuclides)IBA
12/2021
-
09/2018 |
6 | Immunoglobulin G (IgG)IBA
01/2021
-
02/2013 |
5 | Biomarkers (Surrogate Marker)IBA
12/2021
-
01/2016 |
5 | PorphyrinsIBA
12/2019
-
09/2017 |
5 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2018
-
01/2016 |
5 | Proteins (Proteins, Gene)FDA Link
01/2018
-
08/2011 |
4 | AntioxidantsIBA
06/2020
-
12/2018 |
4 | Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019
-
10/2016 |
4 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
-
04/2012 |
4 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015
-
01/2012 |
3 | daratumumabIBA
01/2021
-
01/2017 |
3 | Deferoxamine (Desferal)FDA LinkGeneric
12/2019
-
01/2018 |
3 | 2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2019
-
03/2014 |
3 | Zirconium-89IBA
09/2018
-
01/2016 |
3 | Chelating AgentsIBA
09/2018
-
01/2018 |
3 | LigandsIBA
01/2017
-
03/2012 |
3 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2015
-
12/2012 |
3 | MicellesIBA
12/2014
-
04/2012 |
2 | Cisplatin (Platino)FDA LinkGeneric
01/2023
-
06/2020 |
2 | RadiopharmaceuticalsIBA
12/2021
-
12/2018 |
2 | Immune Checkpoint InhibitorsIBA
01/2021
-
01/2021 |
2 | CarbonIBA
06/2020
-
04/2016 |
2 | IRDye 800CWIBA
01/2019
-
08/2012 |
2 | tetracarboxyphenylporphineIBA
11/2018
-
09/2017 |
2 | Photosensitizing Agents (Photosensitizers)IBA
11/2018
-
01/2017 |
2 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2018
-
09/2017 |
2 | Liposomes (Liposome)IBA
03/2018
-
01/2017 |
2 | polyoxometalateIBA
01/2018
-
10/2017 |
2 | ALT-836IBA
10/2017
-
11/2012 |
2 | Thromboplastin (Tissue Factor)IBA
10/2017
-
11/2012 |
2 | PolymersIBA
08/2017
-
01/2016 |
2 | Insulin (Novolin)FDA Link
01/2017
-
01/2016 |
2 | Insulin-Like PeptidesIBA
01/2016
-
10/2014 |
2 | NanoconjugatesIBA
01/2015
-
01/2015 |
2 | Sunitinib (Sutent)FDA Link
01/2015
-
12/2014 |
2 | graphene oxideIBA
01/2015
-
04/2013 |
2 | IntegrinsIBA
08/2014
-
04/2012 |
2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
05/2013
-
08/2011 |
2 | haloalkane dehalogenase (alkylhalidase)IBA
01/2013
-
08/2011 |
2 | ParaquatIBA
08/2011
-
03/2009 |
1 | Povidone (Crospovidone)IBA
01/2023 |
1 | CurcuminIBA
01/2023 |
1 | Surface Antigens (Surface Antigen)IBA
01/2022 |
1 | Glycoproteins (Glycoprotein)IBA
01/2022 |
1 | Staphylococcal Protein A (Protein A)IBA
12/2021 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021 |
1 | ChemokinesIBA
01/2021 |
1 | CytokinesIBA
01/2021 |
1 | Interleukin-2 (IL2)IBA
01/2021 |
1 | InterferonsIBA
01/2021 |
1 | Yttrium-86IBA
01/2021 |
1 | Dopamine (Intropin)FDA LinkGeneric
01/2021 |
1 | Interleukin-10 (Interleukin 10)IBA
01/2021 |